top of page
  • Regulatory House

SÚKL has published a Notice of rapid binding of the text of the European Pharmacopoeia

Czech State Institute for Drug Control has informed about rapid binding of the text for Candesartanum cilexetilum (2573), Irbesartanum (2465), Losartanum kalicum (2232), Olmesartanum medoxomilum (2600), Valsartanum (2423) since 1.4.2021 and provides the czech translation of these monographs on its website. These monographs will be published in the Supplement 2022 of the Czech Pharmacopoeia.


For more information click here.

0 views0 comments

Recent Posts

See All

Which products cannot be registered?

SÚKL has published several types of products on its website for which it is no longer possible to apply for registration as a medicinal product, as they do not meet the definition under Section 2 of A

Comentarios


bottom of page